8h
Zacks Investment Research on MSN3 Stocks to Watch in the Evolving Cell-Based Ophthalmic Therapy SpaceCell therapy is emerging as a cutting-edge precision treatment in ophthalmology and is gaining immense popularity worldwide among people affected by degenerative eye diseases. Traditional therapies ...
Artificial sweeteners' effects on the gut microbiome are under scrutiny, with evidence suggesting potential risks to ...
21d
Medical Device Network on MSNShoulder Innovations secures $40m to advance arthroplasty systemsShoulder Innovations has secured $40m in a Series E equity financing round, to mainly progress the commercialisation of its InSet Total Shoulder and Reverse Shoulder Arthroplasty Systems. The proceeds ...
Latigo Biotherapeutics, Vivace Therapeutics, and Vori Health each announced the recent successful closing of their respective ...
Microalgae have emerged as a promising bioresource for sustainable biotechnological applications, aligning with global efforts towards eco-friendly ...
Last week, Lilly's newly-opened Lilly Gateway Labs in Beijing welcomed its first tenant, namely a Chinese biotechnology company ... are choosing to license their innovations to global giants ...
China is at the beginning of a long innovation story, according to speakers at the HSBC Global Investment Summit.
A recent survey of public spending on biotechnology in Europe suggests ... took place with the realization that technologies and innovations were being transferred to foreign firms, rather than ...
BEIJING, March 27 (Xinhua) -- Multinational pharmaceutical firms, particularly U.S. giants, are increasingly recognizing China's burgeoning innovative drug sector as a strategic goldmine to bolster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results